Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?

Mancinelli, Chiara Rosa; Scarpazza, C; Santuccio, G; De Rossi, N; Capra, R

Mancinelli, Chiara Rosa; Scarpazza, C; Santuccio, G; De Rossi, N; Capra, R.

Affiliation

Mancinelli CR; Multiple Sclerosis Centre, Spedali Civili di Brescia, Via Ciotti 154, 25018, Montichiari, Brescia, Italy. mancinellichiara86@gmail.com.
Scarpazza C; Multiple Sclerosis Centre, Spedali Civili di Brescia, Via Ciotti 154, 25018, Montichiari, Brescia, Italy.
Santuccio G; Multiple Sclerosis Centre, Sondrio Hospital, ASST Valtellina-Alto Lario, 23100, Sondrio, Italy.
De Rossi N; Multiple Sclerosis Centre, Spedali Civili di Brescia, Via Ciotti 154, 25018, Montichiari, Brescia, Italy.
Capra R; Multiple Sclerosis Centre, Spedali Civili di Brescia, Via Ciotti 154, 25018, Montichiari, Brescia, Italy.

Neurol Sci ; 39(5): 965-966, 2018 05.

Article in En | MEDLINE | ID: mdl-29302813

Subject(s)

Immunologic Factors/adverse effects; Leukoencephalopathy, Progressive Multifocal/chemically induced; Natalizumab/adverse effects; Adult; Antigens, CD20/metabolism; Disability Evaluation; Female; Humans; Leukoencephalopathy, Progressive Multifocal/diagnostic imaging; Magnetic Resonance Imaging; Multiple Sclerosis/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukoencephalopathy, Progressive Multifocal / Natalizumab / Immunologic Factors Type of study: Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2018 Document type: Article Affiliation country: Italy Country of publication: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google